Abstract
Sphingolipids are essential membrane components, present in all eukaryotic cells, but structurally distinct in mammalian and fungal cells. Therefore, they represent an attractive new target for the development of novel antimycotics. This review will briefly highlight sphingolipid biosynthesis and functions in the yeast Saccharomyces cerevisiae. In addition, naturally occurring antifungal compounds that interact with fungal-specific sphingolipids, resulting in fungal growth arrest, will be discussed regarding their mode of action, and therapeutic value. These compounds include plant and insect defensins, syringomycin E and antifungal antibodies to sphingolipids.
Keywords: mode of action, sphingolipid, defensin, syringomycin E, anti-GlcCer antibody, antifungal
Current Drug Targets
Title: Fungal Sphingolipids as Targets for the Development of Selective Antifungal Therapeutics
Volume: 6 Issue: 8
Author(s): K. Thevissen, I.E. J.A. Francois, A. M. Aerts and B. P.A. Cammue
Affiliation:
Keywords: mode of action, sphingolipid, defensin, syringomycin E, anti-GlcCer antibody, antifungal
Abstract: Sphingolipids are essential membrane components, present in all eukaryotic cells, but structurally distinct in mammalian and fungal cells. Therefore, they represent an attractive new target for the development of novel antimycotics. This review will briefly highlight sphingolipid biosynthesis and functions in the yeast Saccharomyces cerevisiae. In addition, naturally occurring antifungal compounds that interact with fungal-specific sphingolipids, resulting in fungal growth arrest, will be discussed regarding their mode of action, and therapeutic value. These compounds include plant and insect defensins, syringomycin E and antifungal antibodies to sphingolipids.
Export Options
About this article
Cite this article as:
Thevissen K., Francois J.A. I.E., Aerts M. A. and Cammue P.A. B., Fungal Sphingolipids as Targets for the Development of Selective Antifungal Therapeutics, Current Drug Targets 2005; 6 (8) . https://dx.doi.org/10.2174/138945005774912771
DOI https://dx.doi.org/10.2174/138945005774912771 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural and Synthetic Naphthoquinones Active Against Trypanosoma Cruzi: An Initial Step Towards New Drugs for Chagas Disease
Current Medicinal Chemistry Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy
Current Stem Cell Research & Therapy Role of Carbon Monoxide in Kidney Function: Is a little Carbon Monoxide Good for the Kidney?
Current Pharmaceutical Biotechnology Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
Current Drug Discovery Technologies Hypersensitivity Reactions to Anticoagulant Drugs
Current Pharmaceutical Design Application of DODMA and Derivatives in Cationic Nanocarriers for Gene Delivery
Current Organic Chemistry A Review of the Three-Dimensional Cell Culture Technique: Approaches, Advantages and Applications
Current Stem Cell Research & Therapy Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Current Drug Delivery Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer
Current Pharmaceutical Biotechnology Innate and Adaptive Immune Responses in Chronic HCV Infection
Current Drug Targets Clinical Uses of 22-Oxacalcitriol
Current Vascular Pharmacology Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration
Current Pharmaceutical Design Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
Current Pharmaceutical Design Human Umbilical Cord Mesenchymal Stem Cells Therapy for Insulin Resistance: A Novel Strategy in Clinical Implication
Current Stem Cell Research & Therapy Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
Current Medicinal Chemistry Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews A Novel Method Aimed at Counteracting the Side Effects Caused by Prostaglandin E<sub>2</sub> Deficiency During Non-Steroidal Anti-Inflammatory Drug Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Evaluation of Inflammatory Biomarkers in Iranian Patients with Cystic Fibrosis
Current Respiratory Medicine Reviews The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells
Drug Metabolism Letters Design of Potentiometric Sensors Based on Interaction of Cyclodextrins with the Enantiomer of Interest
Current Drug Therapy